Quantcast

Justices reject Frosh’s bid to save generic drugs law

Statute was aimed at preventing price gouging

The U.S. Supreme Court on Tuesday rang a death knell for a Maryland law aimed at preventing unwarranted price increases of generic drugs. The justices let stand without comment a 4th U.S. Circuit Court of Appeals decision that the state’s effort to regulate generic drug transactions occurring outside the state violates the Constitution’s Commerce Clause. The ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*